stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
SCHEDULE 13G - Zentalis Pharmaceuticals, Inc. | StockGist | StockGist
Companies
ZNTL
SCHEDULE 13G
stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
Home
Filings
ZNTL
SCHEDULE 13G
SCHEDULE 13G
Beneficial Ownership
Zentalis Pharmaceuticals, Inc.
Filed Dec 30, 2025
Accepted Dec 29, 2025, 7:00 PM ET
ZNTL
CIK 0001725160
View on SEC.gov
Company Profile
0001873515-25-000004
Beneficial Ownership Report
Passive Investment
Shares Owned
0
Reporting Person
Zentalis Pharmaceuticals, Inc.
Person Type
OO
CUSIP: 98943L107
Amendment History
3 filings
SCHEDULE 13G
Original
Viewing
Dec 30, 2025
0001873515-25-000004
SCHEDULE 13G/A
Amendment 1
Dec 6, 2024
0000315066-24-002990
SCHEDULE 13G/A
Amendment 2
Latest
Jan 5, 2026
0001213900-26-001456